28337257|t|Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3beta.
28337257|a|Memory deterioration and synapse damage with accumulation of beta-amyloid and hyperphosphorylated tau are hallmark lesions of Alzheimer's disease (AD). Methylglyoxal (MG), a key intermediate of glucose metabolism, is elevated in AD brains and modifies Abeta42, increasing misfolding and leading to the accumulation of senile plaques. Liraglutide, an analog of glucagon-like peptide-1 (GLP-1), is neurotrophic and neuroprotective. However, whether liraglutide can protect against AD-like memory-related deficits and tau hyperphosphorylation caused by MG in vivo is not known. Here, we report that MG induces tau hyperphosphorylation and causes ultrastructural hippocampal damage and cognitive impairment in C57BL/6J mice. Liraglutide reduced these effects via activation of the protein kinase B and glycogen synthase kinase-3beta pathways. Our data reveal that liraglutide may alleviate AD-like cognitive impairment by decreasing the phosphorylation of tau.
28337257	37	50	methylglyoxal	Chemical	MESH:D011765
28337257	59	73	Alzheimer-like	Disease	MESH:D000544
28337257	74	77	tau	Disease	MESH:C536599
28337257	92	112	cognitive impairment	Disease	MESH:D003072
28337257	156	186	glycogen synthase kinase-3beta	Gene	56637
28337257	188	208	Memory deterioration	Disease	MESH:D008569
28337257	213	227	synapse damage	Disease	MESH:D020263
28337257	314	333	Alzheimer's disease	Disease	MESH:D000544
28337257	335	337	AD	Disease	MESH:D000544
28337257	340	353	Methylglyoxal	Chemical	MESH:D011765
28337257	355	357	MG	Chemical	MESH:D011765
28337257	382	389	glucose	Chemical	MESH:D005947
28337257	417	419	AD	Disease	MESH:D000544
28337257	548	571	glucagon-like peptide-1	Gene	14526
28337257	573	578	GLP-1	Gene	14526
28337257	667	669	AD	Disease	MESH:D000544
28337257	675	698	memory-related deficits	Disease	MESH:D008569
28337257	738	740	MG	Chemical	MESH:D011765
28337257	784	786	MG	Chemical	MESH:D011765
28337257	847	865	hippocampal damage	Disease	MESH:D000092223
28337257	870	890	cognitive impairment	Disease	MESH:D003072
28337257	894	902	C57BL/6J	CellLine	CVCL:C0MW
28337257	903	907	mice	Species	10090
28337257	986	1016	glycogen synthase kinase-3beta	Gene	56637
28337257	1074	1076	AD	Disease	MESH:D000544
28337257	1082	1102	cognitive impairment	Disease	MESH:D003072
28337257	Positive_Correlation	MESH:D011765	MESH:D008569
28337257	Positive_Correlation	MESH:D011765	MESH:C536599
28337257	Positive_Correlation	MESH:D011765	MESH:D000092223
28337257	Positive_Correlation	MESH:D011765	MESH:D003072
28337257	Positive_Correlation	MESH:D011765	MESH:D000544
28337257	Association	MESH:D005947	MESH:D011765

